Literature DB >> 10320415

Neuropsychiatric Aspects of Fragile X Syndrome.

.   

Abstract

Fragile X Syndrome (FXS) is an important cause of both mental retardation and neuropsychiatric disorders, producing its effects by a novel genetic mechanism. Complexities of interacting variables: intelligence quotient (IQ), subject age, limitations of neuropsychiatric testing modalities on the one hand, and the complex genetic mechanism on the other, render exact correspondences between genetic, neural, and neuropsychiatric variables problematic. Nevertheless, current research trends show a convergence of genetic, embryologic, neurocognitive, and neurobehavioral studies on an understanding of pathogenesis centered on the protein product of FMR1, FMRP, with a spectrum of neurocognitive and neuropsychiatric dysfunctions and deficits in turn depending upon tissue mosaicism and other factors determining FMRP production in critical tissues. The resulting neurobehavioral phenotype includes deficits in short-term memory, sequential information processing and visual/spatial abilities, pragmatic language abnormalities, dysfunctional social behavior with peers (gaze-avoidance, aloofness), unusual responses to sensory stimuli, and stereotypy. The proposed psychiatric phenotype now includes attention-deficit hpyeractivity disorder (ADHD), avoidant disorder, pervasive developmental disorders, anziety disorders, mood disorders, and schizotypal personality disorder.

Entities:  

Year:  1996        PMID: 10320415     DOI: 10.1053/SCNP00100154

Source DB:  PubMed          Journal:  Semin Clin Neuropsychiatry        ISSN: 1084-3612


  5 in total

1.  Discrimination learning and attentional set formation in a mouse model of Fragile X.

Authors:  Kimberly S Casten; Annette C Gray; Rebecca D Burwell
Journal:  Behav Neurosci       Date:  2011-06       Impact factor: 1.912

Review 2.  Fragile X-associated disorders: a clinical overview.

Authors:  Anne Gallagher; Brian Hallahan
Journal:  J Neurol       Date:  2011-07-12       Impact factor: 4.849

3.  Diagnosing Autism in Individuals with Known Genetic Syndromes: Clinical Considerations and Implications for Intervention.

Authors:  Susan L Hepburn; Eric J Moody
Journal:  Int Rev Res Dev Disabil       Date:  2011

4.  Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety.

Authors:  Tori L Schaefer; Matthew H Davenport; Lindsay M Grainger; Chandler K Robinson; Anthony T Earnheart; Melinda S Stegman; Anna L Lang; Amy A Ashworth; Gemma Molinaro; Kimberly M Huber; Craig A Erickson
Journal:  J Neurodev Disord       Date:  2017-06-12       Impact factor: 4.025

5.  Fragile X syndrome: a pilot proton magnetic resonance spectroscopy study in premutation carriers.

Authors:  Brian P Hallahan; Eileen M Daly; Andrew Simmons; Caroline J Moore; Kieran C Murphy; Declan D G Murphy
Journal:  J Neurodev Disord       Date:  2012-08-30       Impact factor: 4.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.